The $137 Billion Wake-Up Call: What Operation TrialBlazer Really Changes for Sponsors The US Department of Health and Human Services launched Operation TrialBlazer, one of the most ambitious clinical research initiatives in years. While many of its proposals are still under consultation, the message is clear: the US wants to accelerate clinical development and strengthen its global competitiveness. Why now A few numbers explain why HHS is Read more
Clinical Research Focus 54th Edition June | Cromos Pharma
Clinical Research Focus. 54th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of July 2026. Read more
BIO 2026 Highlights | Cromos Pharma
BIO 2026: Five Industry Shifts That Will Shape Clinical Development Over the Next Few Years Discover five key industry shifts from BIO 2026 shaping the future of clinical development: global thinking, operational excellence, and smarter execution. Read more
How to Choose a CRO for Phase 1 and Phase 2 Clinical Trials  Selecting a CRO for an early-phase study is a different decision than selecting one for a large, late-phase trial. For a broader overview of what a CRO does across all trial phases, including cost drivers and common mistakes, see our CRO clinical trials guide. This article focuses specifically on the criteria that matter most when your study Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us